|
MECOM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.62447832963153E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
9.843000E-03 |
| Stage1-vs-Stage2 |
5.280800E-01 |
| Stage1-vs-Stage3 |
5.229200E-01 |
| Stage1-vs-Stage4 |
3.334200E-01 |
| Stage2-vs-Stage3 |
2.193200E-01 |
| Stage2-vs-Stage4 |
2.840000E-01 |
| Stage3-vs-Stage4 |
3.851000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.46549439250521E-14 |
| Normal-vs-Asian |
4.65339999977665E-07 |
| Caucasian-vs-AfricanAmerican |
1.164160E-01 |
| Caucasian-vs-Asian |
3.291800E-01 |
| AfricanAmerican-vs-Asian |
9.646800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62581059726108E-12 |
| Male-vs-Female |
2.207700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.105427357601E-12 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
2.23070006910575E-10 |
| Normal_Weight-vs-Extreme_Weight |
6.857700E-02 |
| Normal_Weight-vs-Obese |
1.948620E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.625600E-01 |
| Extreme_Weight-vs-Obese |
1.457620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.800800E-01 |
| Obese-vs-Extreme_Obese |
9.499200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.01030295240889E-14 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
<1E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.009600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.600800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.084400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.158000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.817400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.221300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
5.379700E-02 |
| Normal-VS-Unclassified PRCC |
1.11022302462516E-16 |
| Type1 PRCC-VS-Type2 PRCC |
4.225500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.948000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.652300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.254610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.029200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.313800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62470037423645E-12 |
| Normal-vs-N2 |
6.192600E-01 |
| N0-vs-N1 |
1.835230E-03 |
| N0-vs-N2 |
3.517200E-01 |
| N1-vs-N2 |
4.254600E-01 |
|
|
